BERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat Neurological Disorders such as Parkinson’s Disease
Collaboration to Focus on a Disease Target in Parkinson’s Disease With Berg’s Interrogative Biology Technology BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, ...